Obsidian Therapeutics

OBXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.697 B

$27.50 -3.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#129SepternaSEPN$1.75B
#130ZymeworksZYME$1.72B
#131Obsidian TherapeuticsOBX$1.70B
#132AnaptysbioANAB$1.68B
#133Maravai LifesciencesMRVI$1.61B

Where these numbers come from

Share counts and financials for Obsidian Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.